Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.42 |
| ▸ | ATR | Q13535 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.41 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6019292 | 0.85 | LMNA (0.51) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL1085471 | 0.84 | LMNA (0.57) | LMNAPOLBS1PR1S1PR3ATM | |
| SCHEMBL6019010 | 0.84 | ATM (0.47) | S1PR1S1PR3ATMATR | |
| SCHEMBL13936356 | 0.83 | LMNA (0.56) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL29369397 | 0.83 | LMNA (0.56) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL303186 | 0.83 | LMNA (0.56) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL122740 | 0.83 | LMNA (0.56) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL27737488 | 0.82 | POLB (0.55) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL302989 | 0.82 | POLB (0.61) | LMNAPOLBATMNTRK1STING1 | |
| SCHEMBL4100577 | 0.81 | LMNA (0.54) | LMNAPOLBATMNTRK1STING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060178513-A1 | Pyridinylanilides | BAYER CROPSCIENCE AG (DE) | 2006-08-10 | — | — | US | disclosed |
| EP-1656020-A2 | PYRIDINYLANILIDES | Bayer CropScience AG (DE) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005004606-A2 | PYRIDINYLANILIDES | BAYER CROPSCIENCE AG (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178513-A1 | Pyridinylanilides | C3AR1, C5, PADI1 | LMNA 3099/4885POLB 930/4885S1PR1 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.